Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.39 USD | +0.26% |
|
+1.24% | +22.08% |
06-11 | LiveRamp, Walgreens Advertising Group Partner on Data Collaboration | MT |
06-10 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Capitalization | 9.85B 8.52B 8B 7.25B 13.38B 848B 15.13B 93.47B 36.37B 388B 36.98B 36.18B 1,419B | P/E ratio 2025 * |
-2.93x | P/E ratio 2026 * | -36.8x |
---|---|---|---|---|---|
Enterprise value | 16.14B 13.96B 13.1B 11.87B 21.92B 1,390B 24.79B 153B 59.58B 636B 60.58B 59.27B 2,324B | EV / Sales 2025 * |
0.11x | EV / Sales 2026 * | 0.11x |
Free-Float |
60.68% | Yield 2025 * |
6.34% | Yield 2026 * | 7.37% |
More valuation ratios
* Estimated data
More news
Last Transcript: Walgreens Boots Alliance, Inc.
More recommendations
More press releases
More news
1 day | +0.26% | ||
1 week | +1.24% | ||
Current month | +1.24% | ||
1 month | +2.34% | ||
3 months | +1.42% | ||
6 months | +9.62% | ||
Current year | +22.08% |
1 week | 11.26 | ![]() | 11.42 |
1 month | 11.1 | ![]() | 11.42 |
Current year | 9.07 | ![]() | 13.25 |
1 year | 8.08 | ![]() | 16.25 |
3 years | 8.08 | ![]() | 42.74 |
5 years | 8.08 | ![]() | 57.05 |
10 years | 8.08 | ![]() | 97.3 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 65 | 22/10/2023 | |
Manmohan Mahajan
DFI | Director of Finance/CFO | 46 | 26/07/2023 |
Neal Sample
CTO | Chief Tech/Sci/R&D Officer | 50 | 30/09/2023 |
Director | Title | Age | Since |
---|---|---|---|
Stefano Pessina
CHM | Chairman | 84 | 14/03/2021 |
Jan Babiak
BRD | Director/Board Member | 67 | 31/03/2012 |
Director/Board Member | 70 | 30/09/2006 |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.26% | +1.24% | -26.75% | -71.67% | 9.85B | ||
-2.05% | +2.78% | +65.45% | -22.55% | 16.59B | ||
-3.16% | +2.22% | +31.43% | -2.95% | 9.44B | ||
-0.04% | -0.93% | +33.66% | +69.97% | 7.8B | ||
-3.43% | -4.52% | +17.14% | +29.21% | 4.83B | ||
-2.37% | -1.90% | -6.35% | -19.51% | 4.39B | ||
-1.57% | -4.87% | -14.32% | -10.32% | 4.22B | ||
+0.10% | -1.15% | +26.38% | +4.58% | 3.65B | ||
-0.42% | +2.02% | -28.56% | +90.50% | 3.04B | ||
-2.57% | -5.84% | -6.12% | -29.77% | 2.58B | ||
Average | -1.52% | +0.14% | +9.20% | +3.75% | 6.64B | |
Weighted average by Cap. | -1.55% | +0.90% | +20.63% | -5.05% |
2025 * | 2026 * | |
---|---|---|
Net sales | 152B 131B 123B 111B 206B 13,049B 233B 1,438B 559B 5,974B 569B 557B 21,822B | 154B 133B 125B 113B 209B 13,249B 236B 1,460B 568B 6,065B 578B 565B 22,156B |
Net income | -3.36B -2.91B -2.73B -2.47B -4.56B -289B -5.16B -31.87B -12.4B -132B -12.61B -12.34B -484B | -453M -392M -368M -333M -615M -38.98B -695M -4.3B -1.67B -17.85B -1.7B -1.66B -65.19B |
Net Debt | 6.29B 5.44B 5.1B 4.62B 8.54B 541B 9.66B 59.65B 23.21B 248B 23.6B 23.09B 905B | 6.84B 5.92B 5.56B 5.03B 9.29B 589B 10.51B 64.93B 25.27B 270B 25.69B 25.13B 985B |
More financial data
* Estimated data
Employees
252,500
Sector
Drug Retailers
Calendar
Date | Price | Change | Volume |
---|---|---|---|
13/06/25 | 11.39 $ | +0.26% | 6,887,287 |
12/06/25 | 11.36 $ | +0.18% | 3,586,225 |
11/06/25 | 11.34 $ | -0.09% | 3,724,043 |
10/06/25 | 11.35 $ | +0.18% | 7,114,361 |
09/06/25 | 11.33 $ | +0.71% | 7,097,147 |
Delayed Quote Nasdaq, June 13, 2025 at 09:00 pm
More quotesSell
Buy

Mean consensus
HOLD
Number of Analysts
14
Last Close Price
11.39USD
Average target price
12.41USD
Spread / Average Target
+8.98%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- WBA Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition